Literature DB >> 22046579

Capsaicin-sensitive afferentation represents an indifferent defensive pathway from eradication in patients with H. pylori gastritis.

Lilla Lakner1, András Dömötör, Csaba Tóth, Imre L Szabó, Agnes Meczker, Rebeka Hajós, László Kereskai, György Szekeres, Zoltán Döbrönte, Gyula Mózsik.   

Abstract

AIM: To study the role of capsaicin-sensitive afferent nerves in Helicobacter pylori (H. pylori) positive chronic gastritis before and after eradication.
METHODS: Gastric biopsy samples were obtained from corpus and antrum mucosa of 20 healthy human subjects and 18 patients with H. pylori positive chronic gastritis (n = 18) before and after eradication. Traditional gastric mucosal histology (and Warthin-Starry silver impregnation) and special histochemical examinations were carried out. Immunohistochemistry for capsaicin receptor (TRVP1), calcitonin gene-related peptide (CGRP) and substance P (SP) were carried out by the labeled polymer immunohistological method (Lab Vision Co., USA) using polyclonal rabbit and rat monoclonal antibodies (Abcam Ltd., UK).
RESULTS: Eradication treatment was successful in 16 patients (89%). Seven patients (7/18, 39%) remained with moderate complaints, meanwhile 11 patients (11/28, 61%) had no complaints. At histological evaluation, normal gastric mucosa was detected in 4 patients after eradication treatment (4/18, 22%), and moderate chronic gastritis could be seen in 14 (14/18, 78%) patients. Positive immuno-staining for capsaicin receptor was seen in 35% (7/20) of controls, 89% (16/18, P < 0.001) in patients before and 72% (13/18, P < 0.03) after eradication. CGRP was positive in 40% (8/20) of controls, and in 100% (18/18, P < 0.001) of patients before and in 100% (18/18, P < 0.001) after eradication. The immune-staining of gastric mucosa for substance-P was positive in 25% (5/20) of healthy controls, and in 5.5% (3/18, P > 0.05) of patients before and in 0% of patients (0/18, P > 0.05) after H. pylori eradication.
CONCLUSION: Distibution of TRVP1 and CGRP is altered during the development of H. pylori positive chronic gastritis. The immune-staining for TRVP1, CGRP and SP rwemained unchanged before and after H. pylori eradication treatment. The capsaicin-sensitive afferentation is an independent from the eradication treatment. The 6 wk time period might not be enough time for the restituion of chronic H. pylori positive chronic gastritis. The H. pylori infection might not represent the main pathological factor in the development of chronic gastritis.

Entities:  

Keywords:  Afferent and efferent vagal nerves; Calcitonin gene-related peptide; Capsaicin-sensitive afferentation; Eradication therapy; Helicobacter pylori; Substance P; Transient potential vanilloid receptor 1

Year:  2011        PMID: 22046579      PMCID: PMC3205120          DOI: 10.4292/wjgpt.v2.i5.36

Source DB:  PubMed          Journal:  World J Gastrointest Pharmacol Ther        ISSN: 2150-5349


  27 in total

1.  A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology.

Authors:  Barik A Salih; M Fatih Abasiyanik; Huseyin Saribasak; Osman Huten; Ersan Sander
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

2.  Participation of vanilloid/capsaicin receptors, calcitonin-gene-related peptide and substance P in gastric protection of omeprazole and omeprazole-like compounds.

Authors:  Gyula Mózsik; Zsanett Peidl; János Szolcsányi; András Dömötör; Kálmán Hideg; György Szekeres; Oszkár Karádi; Béla Hunyady
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

3.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

4.  Immunohistochemical distribution of vanilloid receptor, calcitonin-gene related peptide and substance P in gastrointestinal mucosa of patients with different gastrointestinal disorders.

Authors:  András Dömötör; Zsanett Peidl; Aron Vincze; Béla Hunyady; János Szolcsányi; László Kereskay; György Szekeres; Gyula Mózsik
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

Review 5.  The incidence of Helicobacter pylori infection.

Authors:  J Parsonnet
Journal:  Aliment Pharmacol Ther       Date:  1995       Impact factor: 8.171

6.  Neuroimmune link in the mucosa of chronic gastritis with Helicobacter pylori infection.

Authors:  G Sipos; K Altdorfer; E Pongor; L P Chen; E Fehér
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

7.  Sensory neurons mediate protective vasodilatation in rat gastric mucosa.

Authors:  P Holzer; E H Livingston; A Saria; P H Guth
Journal:  Am J Physiol       Date:  1991-03

8.  Gastroprotection induced by capsaicin in healthy human subjects.

Authors:  Gyula Mózsik; János Szolcsányi; István Rácz
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

Review 9.  Forty years in capsaicin research for sensory pharmacology and physiology.

Authors:  János Szolcsányi
Journal:  Neuropeptides       Date:  2004-12       Impact factor: 3.286

10.  Comparison of Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients.

Authors:  Chuan Zhang; Nobutaka Yamada; Yun-Lin Wu; Min Wen; Takeshi Matsuhisa; Norio Matsukura
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.